Internal Medicine
RSSArticles
-
Efficacy of Neuroinvasive Goal-Directed Therapy in Hypoxic Ischemic Brain Injury After Cardiac Arrest
This retrospective observational study found the suggestion of favorable neurological outcomes at six months among out-of-hospital cardiac arrest patients who received interventions to optimally manage intracranial pressure and brain tissue oxygenation compared to standard care.
-
An Assessment of Hospital-Acquired Infections in Critically Ill SARS-CoV-2-Infected Patients
This retrospective analysis of prospectively collected data showed that critically ill patients with SARS-CoV-2 infection are at increased risk for hospital-acquired infections.
-
Treatment and Follow-Up of Acute Pulmonary Embolism: A Multidisciplinary Team Approach
This article will review management of pulmonary embolism based on risk stratification, with an emphasis on the role of a Pulmonary Embolism Response Team as well as appropriate follow-up.
-
Pilocarpine Hydrochloride Ophthalmic Solution 1.25% (Vuity)
Pilocarpine ophthalmic solution (OS) can be prescribed to treat presbyopia.
-
Intensive Monitoring for Asymptomatic Atrial Fibrillation Did Not Prevent Strokes
Screening with an implantable loop recorder resulted in dramatically higher rates of atrial fibrillation detection and ensuing anticoagulation, but without a significant decrease in risk of stroke or systemic embolism by six years of follow-up.
-
Importance of Age in the Application of Coronary Artery Calcium Detection
Using coronary CT strategy as a diagnostic first line in patients with symptoms suggestive of coronary artery obstruction revealed relying on the coronary calcium score alone is inadequate for younger patients with a higher frequency of non-calcified obstructions.
-
Reduce the Risk of Autoimmune Disease with Vitamin D, n-3 Fatty Acid Supplements
A randomized, controlled trial that included older adults showed vitamin D3 2,000 units daily or n-3 fatty acids 1,000 mg daily over five years reduced the incidence of autoimmune diseases 25% to 30%.
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.
-
Researchers: Emergency Providers Missing Chances to Avert Future Opioid Disasters
Investigators express concern about prescribing rates for medication-assisted treatment after ED visits for opioid overdoses recorded between late 2019 and early 2021.